The present invention relates to a composition for inducing CYP2B enzyme containing lelamine as an active ingredient. The present invention relates to a novel specific drug metabolizing enzyme composition for inducing the activity of CYP 2B enzyme and exhibiting selective inducing activity against CYP 2B which is not involved in other CYP activity, Drug metabolism studies for prediction of action and co-administration.
展开▼
